Document Classification

Section Type: RESULTS

Text: Intent-to-treat analysis showed that metformin significantly improved PR and LBR (vs. placebo) in the whole study population (PR : 53. 6 vs. 40. 4 %, P = 0. 006 ; LBR : 41. 9 vs. 28. 8 %, P = 0. 014) and PR in obese women (49. 0 vs. 31. 4 %, P = 0. 04), and there was a similar trend in nonobese (PR : 58. 6 vs. 47. 6 %, P = 0. 09 ; LBR : 46. 7 vs. 34. 5 %, P = 0. 09) and in obese women with regard to LBR (35. 7 vs. 21. 9 %, P = 0. 07).